Ship Healthcare HoldingsSHIP HEALTHCARE HOLDINGS, INC.3360東証プライム卸売業FY ending Mar 2026, consolidated, J-GAAP

Ship Healthcare Holdings FY ending Mar 2026 results

About 71% of Ship Healthcare Holdings's sales come from Medical supplies, with Total pack produce and Life care making up much of the rest.

Out of every ¥100 of sales, about ¥3 is left as operating profit.

Revenue changed +5.9% from the prior year, operating profit -1.2%.

Revenue and profit pattern

Revenue up, profit downRevenue grew faster

Revenue +5.9% · profit -1.2%, calculated from disclosed figures.

Operating leverage: -0.20× (profit growth ÷ revenue growth)

FY ending Mar 2025 → FY ending Mar 2026

Revenue for the FY ending Mar 2026 reached ¥718.2B, up 5.9% from ¥678.2B a year earlier.
Profit did not follow: operating income edged down 1.2% to ¥24.5B, and net income attributable to owners fell 11.5% to ¥13.4B.
Cash generation improved, with operating cash flow up 8.3% to ¥22.1B and free cash flow rising to ¥17.4B.

In medical supplies, new hospitals began using its SPD supply-management service, and a joint contract with several hospitals under different owners got underway, lifting sales.
The hospital building and equipment business had no senior-condominium project completed and sold this year, unlike the year before; delayed parts for energy-saving renovation work and one-off costs such as M&A fees also weighed on its profit.
The pharmacy business held up well, helped by small acquisitions and consolidation that made operations leaner.

Results in the hospital building business swing with how many hospitals relocate, rebuild or expand
Delays, changes or cancellations of large projects can hurt results, and sales tend to bunch up near the fiscal year-end because of hospital budget cycles
Revisions to reimbursement prices and price competition may squeeze earnings in medical supplies

Annual Securities Report (FY ending Mar 2026) / 経営者による財政状態、経営成績及びキャッシュ・フローの状況の分析 · Annual Securities Report (FY ending Mar 2026) / 事業等のリスク

FY ending Mar 2025 → FY ending Mar 2026

For every ¥100 Ship Healthcare Holdings sells, how much goes where, and how much is kept.

FY ending Mar 2026

Gross margin9.3%

Operating margin3.4%

Net margin1.9%

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Revenue by business segment, and the profit each one keeps.

FY ending Mar 2026

Medical supplies¥509.6B
71%
Op. margin 1.5%Industry: Specialty Trading & Wholesale
Total pack produce¥136.6B
19%
Op. margin 7.9%Industry: Hospitals & Medical Services
Life care¥37.3B
5%
Op. margin 5.9%Industry: Nursing Care
Dispensing pharmacy¥34.7B
5%
Op. margin 11.6%Industry: Drugstores & Pharmacies

※ Segment figures include inter-segment sales and do not sum to the company total

Show source documents (6)

EDINET (FSA Japan)
有価証券報告書－第34期(2025/04/01－2026/03/31)
ID S100YJZ32026-06-25Open
EDINET (FSA Japan)
有価証券報告書－第33期(2024/04/01－2025/03/31)
ID S100W7VG2025-06-27Open
EDINET (FSA Japan)
有価証券報告書－第32期(2023/04/01－2024/03/31)
ID S100TSY02024-06-27Open
EDINET (FSA Japan)
有価証券報告書－第31期(2022/04/01－2023/03/31)
ID S100R9RR2023-06-29Open
EDINET (FSA Japan)
有価証券報告書－第30期(令和3年4月1日－令和4年3月31日)
ID S100OKHC2022-06-29Open
EDINET (FSA Japan)
有価証券報告書－第29期(令和2年4月1日－令和3年3月31日)
ID S100LUX32021-06-29Open

Extracted from XBRL: 54 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.